Sr Cell Therapy Account Manager - Western Michigan jobs in United States
cer-icon
Apply on Employer Site
company-logo

Gilead Sciences · 1 month ago

Sr Cell Therapy Account Manager - Western Michigan

Gilead Sciences, through its Kite division, is dedicated to curing cancer with innovative treatments. The Sr Cell Therapy Account Manager will be responsible for educating hospital leaders on Kite products and ensuring successful coordination of patient access and cell journey, while building relationships with key stakeholders in the oncology market.

BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Responsible for meeting with appropriate leaders across the academic hospital to educate and logistically support the use of Kite product(s)
Operate in compliance with all laws, regulations and policies
In collaboration with HQ and Medical teams ensures successful coordination of cell journey and patient access
Collaborate and develop effective relationship with HQ, Medical teams, Therapy Area Experts (TAEs) and key decision makers / influencers
Attend and provide support at professional meetings, reporting on scientific sessions and facilitation
Ability to navigate a complex account environment and understand the needs/issues of various stakeholders at all levels within the account
Collaborate and regularly communicate with colleagues in commercial, quality and medical affairs
Actively gains customer insights, providing timely follow-up on commitments and requests
Provide Medical Affairs and Commercial colleagues with appropriate feedback and insights from interactions with healthcare professionals (HCPs)
Facilitate and provide timely feedback to appropriate management regarding account business trends, changes in the therapeutic landscape, industry issues and business opportunities

Qualification

Oncology market knowledgeCell therapy experienceAccount managementRegulatory compliance knowledgeBusiness acumenStrategic planningCustomer insightsABPI ExamEnglish proficiencyPresentation skillsOrganizational skillsTime managementWritten communicationVerbal communicationTeam collaborationInitiativeProblem solvingFast-paced environment adaptability

Required

Proven track record of high performance
Demonstrated initiative, willingness to do what it takes in support of the customer
Possesses a long term, strategic understanding of the oncology market, ideally in cell therapy
Ability to integrate and lead cross functionally
Working knowledge of regulatory and compliance framework
Strong business acumen and ability to evaluate and apply data to inform decision making
Experience with managing large accounts including strategic planning, problem solving and execution
Significant oncology/hematology experience
Exceptional organizational and time management skills
Outstanding written, verbal and presentation skills with internal and external stakeholders
Demonstrate initiative and a willingness to work hands-on and with a sense of urgency, in a fast-paced, entrepreneurial environment
ABPI Exam
7+ years of relevant experience with Bachelors degree
Very good level of English
Requires some overnight travel – 25%

Preferred

Launch experience within academic hospitals

Benefits

Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans

Company

Gilead Sciences

company-logo
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

H1B Sponsorship

Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)

Funding

Current Stage
Public Company
Total Funding
$4.41B
Key Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B

Leadership Team

leader-logo
Keeley Wettan
Senior Vice President, Legal
linkedin
leader-logo
Patrick Loerch
Senior Vice President, Clinical Data Science
linkedin
Company data provided by crunchbase